(BKYI) BIO-Key International - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US09060C3097

BKYI: Biometric, Fingerprint, Identification, Security, Software, Solutions

BIO-key International, Inc. (NASDAQ:BKYI) specializes in biometric identification technologies and enterprise-grade identity access management (IAM) solutions. The company serves a diverse range of sectors, including corporate, government, and education, both domestically and internationally. Its flagship product, BIO-key PortalGuard, is a cloud-based IAM platform designed to integrate seamlessly with SaaS applications, on-premises systems, and cloud services. PortalGuard IDaaS extends these capabilities, offering a customer-controlled, neutral-by-design identity platform. These solutions enhance security for workforces, student populations, and partner networks, enabling collaboration while minimizing risks. The company also offers BIO-key VST and WEB-key products, as well as Civil and Large-Scale ID Infrastructure solutions, which leverage fingerprint-based biometric technology for advanced identification needs. Under the SideSwipe, EcoID, and SidePass brands, BIO-key provides finger scanners tailored for both enterprise and consumer markets. Originally founded in 1993 as SAC Technologies, the company rebranded as BIO-key International, Inc. in 2002 and is headquartered in Holmdel, New Jersey.

3-Month Forecast: Based on technical and fundamental data, BIO-key International, Inc. (BKYI) is expected to experience continued volatility. The stock is currently trading at $1.22, with a 20-day average volume of 111,098 shares. The SMA 20 ($1.10) and SMA 50 ($1.37) indicate recent fluctuations, with the stock price oscillating above and below these levels. The SMA 200 ($1.30) suggests a potential resistance level. The ATR of $0.22 signals moderate price movement expectations. Fundamentally, the companys market cap of $3.25M and P/S ratio of 0.54 reflect its micro-cap status and potential sensitivity to market sentiment. Over the next three months, BKYI may face headwinds due to its high P/B ratio (29.40) and lack of profitability (P/E: 0.00). Technical support near $1.00 and resistance around $1.50 are key levels to monitor.

Additional Sources for BKYI Stock

BKYI Stock Overview

Market Cap in USD 3m
Sector Industrials
Industry Security & Protection Services
GiC Sub-Industry Systems Software
IPO / Inception 1997-02-14

BKYI Stock Ratings

Growth 5y -87.5%
Fundamental -14.6%
Dividend 0.0%
Rel. Strength -64.9
Analysts 4/5
Fair Price Momentum 0.30 USD
Fair Price DCF -

BKYI Dividends

No Dividends Paid

BKYI Growth Ratios

Growth Correlation 3m -87.2%
Growth Correlation 12m -62.2%
Growth Correlation 5y -98.6%
CAGR 5y -62.26%
CAGR/Max DD 5y -0.62
Sharpe Ratio 12m -1.58
Alpha -67.48
Beta 0.245
Volatility 84.16%
Current Volume 205.6k
Average Volume 20d 199.1k
What is the price of BKYI stocks?
As of April 02, 2025, the stock is trading at USD 0.76 with a total of 205,595 shares traded.
Over the past week, the price has changed by -30.24%, over one month by -25.45%, over three months by -45.29% and over the past year by -64.80%.
Is BIO-Key International a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, BIO-Key International is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -14.57 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BKYI as of April 2025 is 0.30. This means that BKYI is currently overvalued and has a potential downside of -60.53%.
Is BKYI a buy, sell or hold?
BIO-Key International has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy BKYI.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for BKYI stock price target?
According to ValueRays Forecast Model, BKYI BIO-Key International will be worth about 0.3 in April 2026. The stock is currently trading at 0.76. This means that the stock has a potential downside of -56.58%.
Issuer Forecast Upside
Wallstreet Target Price 3 294.7%
Analysts Target Price 3 294.7%
ValueRay Target Price 0.3 -56.6%